DongBang Medical Raises 32.4 Billion KRW via KOSDAQ IPO with 15% Share Dilution, Funds Used for Facility Expansion and Debt Repayment

DongBang Medical issued 3,090,000 new shares at 10,500 KRW per share in February 2025 for its KOSDAQ listing, raising approximately 32.4 billion KRW, resulting in a 14.8% dilution of total outstanding shares.
The proceeds were allocated to facility investment of 4.7 billion KRW, working capital of 5.5 billion KRW, debt repayment of 9.4 billion KRW, and acquisition of other company securities of 11.4 billion KRW, laying the foundation for growth through production capacity expansion and overseas subsidiary investments.
The company's consolidated debt ratio stands at a stable 48.8%, and net profit of 11.4 billion KRW increased retained earnings. No dividends were paid.
[AI Summary]DongBang Medical raised significant capital through its IPO, but the substantial share dilution and the use of a large portion of funds for debt repayment raise questions about capital efficiency. While the investments in facilities and overseas equity may drive long-term growth, they could weigh on short-term stock performance.